All Stories

  1. CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions
  2. LXR Signaling Regulates Macrophage Survival and Inflammation in Response to Ionizing Radiation
  3. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia-Reperfusion Injury in Mice
  4. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort
  5. Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages
  6. Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update
  7. Benzylamine and Thenylamine Derived Drugs Induce Apoptosis and Reduce Proliferation, Migration and Metastasis Formation in Melanoma Cells
  8. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
  9. Protection against gamma-radiation injury by protein tyrosine phosphatase 1B
  10. Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca2+ Handling in a Mouse Model of Heart Failure
  11. Correction: Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels (doi:10.1242/jcs.01002)
  12. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p
  13. GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr−/− mice
  14. Prostaglandin E2 Impairs P2Y2/P2Y4 Receptor Signaling in Cerebellar Astrocytes via EP3 Receptors
  15. Expression of Concern: Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels. J. Cell Sci. doi: 10.1242/jcs.01002
  16. Mild and Short-Term Caloric Restriction Prevents Obesity-Induced Cardiomyopathy in Young Zucker Rats without Changing in Metabolites and Fatty Acids Cardiac Profile
  17. Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives
  18. Role of NOD1 in Heart Failure Progression via Regulation of Ca 2+ Handling
  19. Cell Expansion-Dependent Inflammatory and Metabolic Profile of Human Bone Marrow Mesenchymal Stem Cells
  20. NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes
  21. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice
  22. New thiazolidinediones affect endothelial cell activation and angiogenesis
  23. GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo
  24. New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice
  25. Activation of autophagy in macrophages by pro-resolving lipid mediators
  26. New indole-thiazolidine attenuates atherosclerosis in LDLr−/− mice
  27. Metabolic signatures linked to macrophage polarization: from glucose metabolism to oxidative phosphorylation
  28. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer
  29. HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages
  30. Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling
  31. NOD1, a new player in cardiac function and calcium handling
  32. A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: Involvement of AKT-dependent mechanisms
  33. NOD1 receptor is up-regulated in diabetic human and murine myocardium
  34. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance
  35. NFκB2/p100 Is a Key Factor for Endotoxin Tolerance in Human Monocytes: A Demonstration Using Primary Human Monocytes from Patients with Sepsis
  36. Anti-inflammatory Actions of Acanthoic Acid-Related Diterpenes Involve Activation of the PI3K p110γ/δ Subunits and Inhibition of NF-κB
  37. P727Nucleotide-binding oligomerization domain-containing protein 1-signaling is upregulated in hearts from type 2 diabetic mice
  38. Mitochondrial DAMPs Induce Endotoxin Tolerance in Human Monocytes: An Observation in Patients with Myocardial Infarction
  39. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD
  40. Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge
  41. Involvement of monocytes/macrophages as key factors in the development and progression of cardiovascular diseases
  42. 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis
  43. Sustained Release of Prostaglandin E2in Fibroblasts Expressing Ectopically Cyclooxygenase 2 Impairs P2Y-Dependent Ca2+-Mobilization
  44. Modulation of Voltage-Dependent and Inward Rectifier Potassium Channels by 15-Epi-Lipoxin-A4 in Activated Murine Macrophages: Implications in Innate Immunity
  45. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma
  46. Progression of liver oncogenesis in the double transgenic mice c-myc/TGF α is not enhanced by cyclooxygenase-2 expression
  47. Prolonged leptin treatment increases transient outward K+ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes
  48. Selective Impairment of P2Y Signaling by Prostaglandin E2 in Macrophages: Implications for Ca2+-Dependent Responses
  49. Identification of a novel Pfkfb1 mRNA variant in rat fetal liver
  50. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells
  51. NOD1 Activation Induces Cardiac Dysfunction and Modulates Cardiac Fibrosis and Cardiomyocyte Apoptosis
  52. Cardiotrophin-1 induces sarcoplasmic reticulum Ca2+ leak and arrhythmogenesis in adult rat ventricular myocytes
  53. Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma
  54. Propiedades antiinflamatorias de los ácidos grasos poliinsaturados omega-3. Indicaciones en oftalmología
  55. Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives
  56. Protein Kinase C (PKC)ζ-mediated GαqStimulation of ERK5 Protein Pathway in Cardiomyocytes and Cardiac Fibroblasts
  57. Relevance of the MEK/ERK Signaling Pathway in the Metabolism of Activated Macrophages: A Metabolomic Approach
  58. Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation
  59. Anti-Inflammatory and Antioxidant Properties of a New Arylidene-Thiazolidinedione in Macrophages
  60. Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression
  61. Transgenic Mice Expressing Cyclooxygenase-2 in Hepatocytes Reveal a Minor Contribution of This Enzyme to Chemical Hepatocarcinogenesis
  62. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C
  63. Benznidazole blocks NF-κB activation but not AP-1 through inhibition of IKK
  64. Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression
  65. Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
  66. Cilastatin Attenuates Cisplatin-Induced Proximal Tubular Cell Damage
  67. Electronegative LDL induction of apoptosis in macrophages: Involvement of Nrf2
  68. ILK mediates LPS-induced vascular adhesion receptor expression and subsequent leucocyte trans-endothelial migration†
  69. Bioactivity of nitrolinoleate: effects on adhesion molecules and CD40–CD40L system☆
  70. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways
  71. Mice Lacking Thyroid Hormone Receptor β Show Enhanced Apoptosis and Delayed Liver Commitment for Proliferation after Partial Hepatectomy
  72. COX-2 in liver, from regeneration to hepatocarcinogenesis: What we have learned from animal models?
  73. Impairment of Transforming Growth Factor β Signaling in Caveolin-1-deficient Hepatocytes
  74. Vasorelaxant and anti-platelet aggregation effects of aqueous Ocimum basilicum extract
  75. Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection
  76. Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury
  77. Implication of Glutamate in the Expression of Inducible Nitric Oxide Synthase After Oxygen and Glucose Deprivation in Rat Forebrain Slices
  78. Supression of inflammatory responses by labdane-type diterpenoids☆
  79. Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages
  80. Selective Impairment of Nuclear Factor-κB-Dependent Gene Transcription in Adult Cardiomyocytes
  81. Atherogenesis takes place in cholesterol-fed rabbits when circulating concentrations of endogenous cortisol are increased and inflammation suppressed
  82. Selective Activation of Liver X Receptors by Acanthoic Acid-Related Diterpenes
  83. Animal models for the study of liver regeneration: role of nitric oxide and prostaglandins
  84. Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells
  85. Identification of conserved domains in the promoter regions of nitric oxide synthase 2: implications for the species-specific transcription and evolutionary differences
  86. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes
  87. Infiltration of Inflammatory Cells Plays an Important Role in Matrix Metalloproteinase Expression and Activation in the Heart during Sepsis
  88. Surgical Excision of Bone Sarcomas Involving the Sacroiliac Joint
  89. Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells
  90. Specific Contribution of p19ARF to Nitric Oxide-Dependent Apoptosis
  91. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells
  92. Involvement of mitogen-activated protein kinases in the symbiosis Bradyrhizobium-Lupinus
  93. Cyclooxygenase 2: understanding the pathophysiological role through genetically altered mouse models
  94. The Nonthiazolidinedione PPARγ Agonist L-796,449 Is Neuroprotective in Experimental Stroke
  95. Potentiation of tumor formation by topical administration of 15-deoxy-Δ 12,14 -prostaglandin J 2 in a model of skin carcinogenesis
  96. Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms
  97. Assessment of a dual regulatory role for NO in liver regeneration after partial hepatectomy: protection against apoptosis and retardation of hepatocyte proliferation
  98. Prostaglandin E 2 promotes migration and adhesion in hepatocellular carcinoma cells
  99. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate
  100. Nitric Oxide and Cell Signaling: In Vivo Evaluation of NO‐Dependent Apoptosis by MRI and Not NMR Techniques
  101. PGE1-induced NO reduces apoptosis by D-galactosamine through attenuation of NF-κB and NOS-2 expression in rat hepatocytes
  102. A New Family of Synthetic Diterpenes that Regulates Cytokine Synthesis by Inhibiting IκBα Phosphorylation
  103. Attenuation of NF-?B signalling in rat cardiomyocytes at birth restricts the induction of inflammatory genes
  104. Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins
  105. The P34G Mutation Reduces the Transforming Activity of K-Ras and N-Ras in NIH 3T3 Cells but Not of H-Ras
  106. Simultaneous abrogation of NOS-2 and COX-2 activities is lethal in partially hepatectomised mice
  107. Thioacetamide-induced liver regeneration involves the expression of cyclooxygenase 2 and nitric oxide synthase 2 in hepatocytes
  108. Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels
  109. Regional distribution of hyperpolarization-activated current (If) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts
  110. Sustained Nitric Oxide Delivery Delays Nitric Oxide-Dependent Apoptosis in Macrophages: Contribution to the Physiological Function of Activated Macrophages
  111. Thromboxane A 2 -Induced Inhibition of Voltage-Gated K + Channels and Pulmonary Vasoconstriction
  112. Induction of Cyclooxygenase-2 Accounts for Restraint Stress-Induced Oxidative Status in Rat Brain
  113. The cyclopentenone 15-deoxy-Δ 12,14 -prostaglandin J 2 binds to and activates H-Ras
  114. The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum
  115. Ammonia prevents glutamate-induced but not low K+-induced apoptosis in cerebellar neurons in culture
  116. PKCε is a permissive link in integrin-dependent IFN-γ signalling that facilitates JAK phosphorylation of STAT1
  117. Selective Inhibitors of Cyclooxygenase-2 Delay the Activation of Nuclear Factor κB and Attenuate the Expression of Inflammatory Genes in Murine Macrophages Treated with Lipopolysaccharide
  118. Potentiation of Protein Kinase C ζ Activity by 15-Deoxy-Δ12,14-Prostaglandin J2 Induces an Imbalance between Mitogen-Activated Protein Kinases and NF-κB That Promotes Apoptosis in Macrophages
  119. Presence of methylated arginine derivatives in orthotopic human liver transplantation: Relevance for liver function
  120. H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis
  121. Interleukin-4 and interleukin-10 modulate nuclear factor κB activity and nitric oxide synthase-2 expression in Theiler's virus-infected brain astrocytes
  122. Induction of apoptosis by nitric oxide in macrophages is independent of apoptotic volume decreas
  123. Coexistence of translocated cytochrome c and nitrated protein in neurons of the rat cerebral cortex after oxygen and glucose deprivation
  124. The Increase in TNF-α Levels Is Implicated in NF-κB Activation and Inducible Nitric Oxide Synthase Expression in Brain Cortex after Immobilization Stress
  125. Absence of nuclear factor κB inhibition by NSAIDs in hepatocytes
  126. Nitric oxide and resolution of inflammation
  127. Chronic Stress Induces the Expression of Inducible Nitric Oxide Synthase in Rat Brain Cortex
  128. Protein Kinase Cϵ Is Required for Macrophage Activation and Defense Against Bacterial Infection
  129. Intracellular water motion decreases in apoptotic macrophages after caspase activation
  130. Contribution of cyclooxygenase-2 to liver regeneration after partial hepatectomy
  131. Peroxisome Proliferator-activated Receptor-γ-independent Inhibition of Macrophage Activation by the Non-thiazolidinedione Agonist L-796,449
  132. Up-regulation of TNF-α convertase (TACE/ADAM17) after oxygen–glucose deprivation in rat forebrain slices
  133. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes
  134. Inhibition of the Nuclear Factor  B (NF- B) Pathway by Tetracyclic Kaurene Diterpenes in Macrophages: SPECIFIC EFFECTS ON NF- B-INDUCING KINASE ACTIVITY AND ON THE COORDINATE ACTIVATION OF ERK AND p38 MAPK
  135. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor κB-mediated mechanisms
  136. Contribution of Cyclopentenone Prostaglandins to the Resolution of Inflammation Through the Potentiation of Apoptosis in Activated Macrophages
  137. Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer-binding proteins
  138. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices
  139. Localisations métastatiques atypiques d’un cancer du rectum
  140. Anti-inflammatory action of type I interferons deduced from mice expressing interferon β
  141. Inhibition of IκB Kinase and IκB Phosphorylation by 15-Deoxy-Δ12,14-Prostaglandin J2 in Activated Murine Macrophages
  142. Inhibitory effect of IGF-I on type 2 nitric oxide synthase expression in Ins-1 cells and protection against activation-dependent apoptosis: involvement of phosphatidylinositol 3-kinase
  143. Inhibition of NOS-2 expression in macrophages through the inactivation of NF-κ B by andalusol
  144. Mechanisms of Nitric Oxide-Dependent Apoptosis: Involvement of Mitochondrial Mediators
  145. Presence of a nitric oxide synthase inhibitor in the graft efflux during reperfusion in human liver transplantation
  146. Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages
  147. Down-Regulation of Neuronal Nitric Oxide Synthase by Nitric Oxide After Oxygen-Glucose Deprivation in Rat Forebrain Slices
  148. Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines
  149. Interferon-α/β Inhibits the Apoptosis Induced by Lipopolysaccharide and Interferon-γ in Murine Peritoneal Macrophages
  150. Suppression of HIV-1 infection in linomide-treated SCID-hu-PBL mice
  151. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices
  152. Differential regulation of nitric oxide synthase mRNA expression by lipopolysaccharide and pro-inflammatory cytokines in fetal hepatocytes treated with cycloheximide
  153. Nuclear factorκB is required for the transcriptional control of type II NO synthase in regenerating liver
  154. Rapid Up-regulation of IκBβ and Abrogation of NF-κB Activity in Peritoneal Macrophages Stimulated with Lipopolysaccharide
  155. Requirement of nitric oxide and calcium mobilization for the induction of apoptosis in adrenal vascular endothelial cells
  156. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition
  157. Absence of NO synthase type II expression in fetal liver from pregnant rats under septic shock conditions
  158. Involvement of nitric oxide synthesis in hepatic perturbations induced in rats by a necrogenic dose of thioacetamide
  159. Expression of the calcium-independent cytokine-inducible (iNOS) isoform of nitric oxide synthase in rat placenta
  160. Regulation of rat liver S-adenosylmethionine synthetase during septic shock: Role of nitric oxide
  161. Up-Regulation of Protein Kinase C-ϵ Promotes the Expression of Cytokine-inducible Nitric Oxide Synthase in RAW 264.7 Cells
  162. Evidence for Common Mechanisms in the Transcriptional Control of Type II Nitric Oxide Synthase in Isolated Hepatocytes
  163. Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development
  164. Bacterial lipopolysaccharide antagonizes transforming growth factor ?1-induced apoptosis in primary cultures of hepatocytes
  165. CD53 Antigen and Epidermal Growth Factor Induce Similar Changes in the Pattern of Phorbol Ester Binding in a B Cell Lymphoma
  166. Characterization of nitric oxide dependent changes in carbohydrate hepatic metabolism during septic shock
  167. Differential regulation of the expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and pyruvate kinase by cyclic adenosine 3′,5′-monophosphate in fetal and adult hepatocytes
  168. Epidermal growth factor inhibits cytokine-dependent nitric oxide synthase expression in hepatocytes
  169. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels.
  170. Bacterial Lipopeptides Induce Nitric Oxide Synthase and Promote Apoptosis through Nitric Oxide-independent Pathways in Rat Macrophages
  171. Nitric oxide is released in regenerating liver after partial hepatectomy*1
  172. Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis
  173. Protein kinase C (PKC)-induced PKC degradation: a model for down-regulation
  174. From Apoptosis to Autoimmunity: Insights from the Signaling Pathways Leading to Proliferation or to Programmed Cell Death
  175. CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating bcl-2 expression
  176. Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes
  177. Protein kinase C V3 domain mutants with differential sensitivities to m-calpain are not resistant to phorbol-ester-induced down-regulation
  178. Induction of nitric oxide release by MRC OX-44 (anti-CD53) through a protein kinase C-dependent pathway in rat macrophages
  179. Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide
  180. Rat liver messenger ribonucleic acid and enzyme activity of 6- phosphofructo 2-kinase/fructose 2,6-bisphosphatase impairment during the late period of pregnancy
  181. Sulfonylureas activate glycogen phosphorylase and increase cytosolic free-Ca2+ levels in isolated rat hepatocytes
  182. Phorbol esters induce nitric oxide synthase and increase arginine influx in cultured peritoneal macrophages
  183. Signal Transduction Pathways Involved in B-Cell Induction
  184. Differential calcium mobilization by vasopressin, angiotensin II, gastrin-releasing peptide, and adenosine triphosphate in adult and fetal hepatocytes. Relevance for the activation of calcium-dependent enzymes
  185. Isoenzymes of carbohydrate metabolism in primary cultures of hepatocytes from thioacetamide-induced rat liver necrosis: Responses to growth factors
  186. Phorbol esters, bombesin and insulin elicit differential responses on the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase system in primary cultures of foetal and adult rat hepatocytes
  187. Inhibition of 6-phosphofructo-2-kinase activity by mercaptopurines
  188. Substrate specificity of protein kinase C inhibitors
  189. Substrate-dependent inhibition of protein kinase C by specific inhibitors
  190. Lack of correlation betwen translocation and biological effects mediated by protein kinase C: an appraisal
  191. Oleate-induced translocation of protein kinase C to hepatic microsomal membranes
  192. Translocation of phosphatidate phosphohydrolase from the cytosol to microsomal membranes in thioacetamide-induced liver tumours in rats
  193. Presence of antibody to A- and B-transferases in minor incompatible bone marrow transplants
  194. Age-related changes in the translocation of phosphatidate phosphohydrolase from the cytosol to microsomal membranes in rat liver
  195. Phorbol 12,13-dibutyrate and mitogens increase fructose 2,6-bisphosphate in lymphocytes. Comparison of lymphocyte and rat-liver 6-phosphofructo-2-kinase
  196. Phorbol ester translocation of protein kinase C in guinea-pig synaptosomes and the potentiation of calcium-dependent glutamate release
  197. Activation of protein kinase C from B lymphocytes by lipid A
  198. Fructose 2,6-bisphosphate in isolated foetal hepatocytes
  199. Phorbol 12-myristate 13-acetate and insulin increase the concentration of fructose 2,6-bisphosphate and stimulate glycolysis in chicken embryo fibroblasts.
  200. The effect of fructose 2,6-bisphosphate on muscle fructose-1,6-bisphosphatase activity
  201. A problematic enzyme
  202. Is phosphofructokinase the rate-limiting step of glycolysis?
  203. Biphasic effect of fructose 2,6-bisphosphate on the liver fructose-1,6-bisphosphatase: mechanistic and physiological implications
  204. Specific activation by fructose 2,6-bisphosphate and inhibition by P-enolpyruvate of ascites tumor phosphofructokinase
  205. Mitochondrial Membrane-Bound Hexokinase of Ascites Tumor Cells. Functional Implications of Lysine Residues Studied by Modification with Imidoesters